TABLE 1.
Vaccine carrier | Physicochemical properties of chitosan NPs based vaccine | Target pathogens | Encapsulated vaccine antigens | Route of delivery; antigen amount; number of vaccine doses | Target animal | Immune correlates and pathogen clearance | References |
Chitosan NPs surface tagged with Salmonella Enteritidis flagellin protein | Low molecular weight chitosan Size: 517 nm Zeta potential: — Shape: spherical | Salmonella Enteritidis | Outer membrane proteins and flagellin protein | Oral; 100 μg; 3 | Layer chickens | Enhanced mucosal IgA antibody, cellular immune response, TLRs gene expression | Renu et al., 2020c |
Chitosan NPs surface tagged with Salmonella Enteritidis flagellin protein | Low molecular weight chitosan; 75–85% deacetylated; 50,000–190,000 Da Size: 514 nm Zeta potential: +40 mV Shape: spherical | Salmonella Enteritidis | Outer membrane proteins and flagellin protein | Oral; 50, 100 and 500 μg; 3 | Layer chickens | Increased TLRs, Th1 and Th2 cytokines mRNA expression, antigen-specific humoral immune response; lower bacterial challenge load in cecum | Renu et al., 2020b |
Chitosan NPs surface tagged with Salmonella Enteritidis flagellin protein | Low molecular weight chitosan Size: — Zeta potential: — Shape: — | Salmonella Enteritidis | Outer membrane proteins and flagellin protein | Oral; 500, 1000 and 2000 μg; 2 | Broiler chickens | Induced cross-reactive IgG and mucosal IgA antibodies, cytokine gene expression; lower heterologous challenge bacterial load in liver and spleen | Acevedo-Villanueva et al., 2020 |
Chitosan NPs surface tagged with Salmonella Enteritidis flagellin protein | Low molecular weight chitosan Size: 300 nm Zeta potential: +40 mV Shape: spherical | Salmonella Enteritidis | Outer membrane proteins and flagellin protein | Oral; 12.5 and 50 μg; 1 and 2 | White Cornish Cross broilers | Increased innate immune response and antigen specific lymphocytes proliferation; lower antigen specific IgA and IgG antibody response | Han et al., 2020c |
Chitosan NPs surface tagged with Salmonella Enteritidis flagellin protein | Low molecular weight chitosan Size: — Zeta potential: — Shape: — | Salmonella Enteritidis | Outer membrane proteins and flagellin protein | Oral; 10 and 50 μg; 1 to 3 | Cornish Cross breed broilers | Robust pre and post-challenge IgG and IgA antibody, cell mediated immune response, TLRs gene expression; reduced challenge bacterial load in the cecum | Han et al., 2020a |
Mannose conjugated chitosan NPs surface tagged with Salmonella Enteritidis flagellin protein | Low molecular weight chitosan Size: — Zeta potential: — Shape: — | Salmonella Enteritidis | Outer membrane proteins and flagellin protein | Oral; 10 μg; 2 | Cornish Cross breed broilers | Enhanced cell mediated immune response, TLRs and balanced Th1 and Th2 cytokine gene expression; reduced Salmonella challenge load in the cecum | Han et al., 2020b |
Chitosan NPs | Size: 167 nm Zeta potential: +20.1 mV Shape: spherical | Campylobacter jejuni | Recombinant hemolysin co-regulated protein | Oral; 50 μg; 3 | Vencobb chicks | Increased secretory IgA and systemic IgY antibody, cytokine gene expression; enhanced bacterial clearance in cecum | Singh et al., 2019 |
Chitosan NPs | 85% deacetylated; 400 kD Size: 80–100 nm Zeta potential: — Shape: spherical | Campylobacter jejuni | flaA gene | Intranasal; 150 μg; 3 | White Leghorn chickens | Increased serum IgG and intestinal mucosal IgA antibody; reduced bacterial shedding by 2–3 log10 in large intestine and cecum | Huang et al., 2010 |
Chitosan NPs | Medium molecular weight chitosan; 75–85% deacetylated Size: — Zeta potential: +19.9 mV Shape: spherical | Avian pathogenic Escherichia coli | ΦKAZ14 bacteriophage | Oral; 107 PFU/mL; 1 | Broiler chicks | Improved body weight; decreased mortality; decreased bacterial colonization in intestines; reduced fecal shedding; increased protection rate | Kaikabo et al., 2017 |
Chitosan NPs surface tagged with HA2 and M2e influenza proteins | Low molecular weight chitosan Size: 100–800 nm Zeta potential: — Shape: spherical | Avian influenza virus | HA2 and M2e mRNAs | Intranasal; 4 μg; 2 | Layer chickens | Increased IgG and mucosal IgA antibody, virus neutralization titers, cell-mediated immune response; lower lung pathology; reduced homologous and heterologous challenge virus titers in cloacal swab | Hajam et al., 2020 |
Chitosan | 85% deacetylated Size: — Zeta potential: — Shape: — | Avian influenza virus | Inactivated split influenza virus | Intranasal; 100 HA units; 1 and 2 | Layer chickens | Enhanced mucosal IgA and HI antibody; resist against lethal virus challenge in field condition | Worrall et al., 2009 |
Chitosan NPs | Medium molecular weight chitosan; 75–85% deacetylated Size: 286 nm Zeta potential: +19.9 mV Shape: spherical | Avian infectious bronchitis virus | Inactivated infectious bronchitis virus | Oculo-nasal; 108.285 EID50 of the virus; 1 | SPF chickens | Enhanced mucosal IgA, IFNγ gene expression; no or mild relevant microscopic lesions; lower viral load in trachea and kidney | Lopes et al., 2018 |
N-2- hydroxypropyl trimethyl ammonium chloride chitosan and N,O-carboxymethyl chitosan NPs | Size: 251.8 and 122.4 nm Zeta potential: 46.6 and 53.2 mV Shape: spherical | Newcastle disease virus and infectious bronchitis virus | Newcastle disease virus and infectious bronchitis virus combined | Intranasal; 107.4 and 105.5 EID50 of the virus; 1 | SPF chickens | Increased IgG and IgA antibodytiters, lymphocyte proliferation, cytokines IL-2, IL-4 and IFN-γ than the commercial live vaccine; complete protection | Zhao et al., 2017 |
N-2-hydroxypropyl trimethyl ammonium chloride chitosan and N,O carboxymethyl chitosan NPs | Size: 309.7 nm Zeta potential: 49.9 mV Shape: spherical | Newcastle disease virus | pVAX I-F(o) | Intranasal; 200 μg; 2 | SPF chickens | Higher IgG and secretory IgA antibody; stimulated lymphocyte proliferation; increased IL-2, IL-4, and IFN-γ levels; complete protection | Zhao et al., 2018 |
N-2-hydroxypropyl trimethyl ammonium chloride chitosan and N,O carboxymethyl chitosan NPs | 85% deacetylated Size: 252.2 nm Zeta potential: +41.1 mV Shape: spherical | Newcastle disease virus | Attenuated live Newcastle disease virus | Oral or intranasal; 107.5 EID50 of the virus; 1 | SPF chickens | Induced high titers of serum antibody; promoted lymphocyte proliferation; higher levels of serum IL-2, IL-4 and IFN- γ; no clinical signs and mortality | Jin et al., 2017 |
N-2-hydroxypropyl trimethyl ammonium chloride chitosan NPs | 85% deacetylated; 71.3 kDa Size: 303.8 nm Zeta potential: 45.7 mV Shape: spherical | Newcastle disease virus | Attenuated live Newcastle disease virus | Oral or intranasal; 107.12 EID50 of the virus; 1 | SPF chickens | Induced robust cellular, humoral and mucosal immune response; absence of pathological changes; complete protection than the commercial attenuated live vaccine | Zhao et al., 2016 |
O-2’ hydroxypropyl trimethyl ammonium chloride chitosan NPs | 85% deacetylated Size: 303.5 nm Zeta potential: +46.3 mV Shape: spherical | Newcastle disease virus | Attenuated live Newcastle disease virus | Oral or intranasal; —; 1 | SPF chickens | Robust cellular, humoral and mucosal immune response; absence of histopathological changes compared to a commercial attenuated live vaccine | Dai et al., 2015 |
Chitosan NPs | 80% deacetylated; 71.3 kDa Size: 199.5 nm Zeta potential: +12.1 mV Shape: spherical | Newcastle disease virus | F gene plasmid DNA | Intranasal; 200 μg; 2 | SPF chickens | Increased IgA and IgG antibodies, lymphocyte proliferation response; absence of clinical symptoms and mortality | Zhao et al., 2014 |
Chitosan NPs | 80% deacetylated; 71.3 kDa Size: 371.1 nm Zeta potential: +2.8 mV Shape: spherical | Newcastle disease virus | Lentogenic live Newcastle disease virus | Oral or intranasal; —; 1 | SPF chickens | Enhanced lymphocyte proliferation, serum HI and intestinal mucus IgA antibody titers; absence of clinical signs and mortality | Zhao et al., 2012 |
Chitosan | 70–95% deacetylated Size: — Zeta potential: — Shape: — | Newcastle disease virus | Live Newcastle disease virus | Oculo-nasal; 106 EID50 of the virus; 1 | SPF white Leghorn chickens | Enhanced cell mediated immune response; no effect on systemic and mucosal antibody mediated immune response | Rauw et al., 2010a |
Chitosan | — | Newcastle disease virus | Live Newcastle disease virus | Oculo-nasal; 106 EID50 of the virus; 1 | Isa Brown layer chickens | Provides protection against mortality and morbidity; reduced virus shedding; higher cellular and mucosal antibody mediated immune response | Rauw et al., 2010b |
NPs, nanoparticles; PFU, plaque forming units; HA, hemagglutinin; EID50, 50% egg infective dose; HI, hemagglutination inhibition; TLRs, toll-like receptors; Th1, T helper type 1; Th2, T helper type 2; IL, Interleukin; and IFNγ, interferon gamma.